Skip to main content

Table 1 Genomic DNA sequencing of the patient and her family’s lymphocyte tissue

From: Diagnostic challenges in a CMMRD patient with a novel mutation in the PMS2 gene: a case report

Patient and her family

Age (years)

Genotype (mutated gene, position, mutation at protein level, mutation at cDNA level)

Homozygous/heterozygous condition

RS number

Polyphen2 score

Minor allele frequency

Patient

16

PMS2 6026819, p.Asp526fs, c.1577delA

Homozygous condition

Mother

45

PMS2 6036980 G>C, p.S260S, c.780 C>G

Heterozygous condition

rs1805319

0.83127

PMS2 6043386 G>A, p.A96A, c.288 C>T

Heterozygous condition

rs12532895

0.11362

Younger brother

5

PMS2 6036980 G>C, p.S260S, c.780 C>G

Homozygous condition

rs1805319

0.83127

PMS2 6043386 G>A, p.A96A, c.288 C>T

Heterozygous condition

rs12532895

0.11362

PMS2 6026775 T>C, p.K541E, c.1621 A>G

Homozygous condition

rs2228006

Benign (0.000)

0.88319

PMS2 6045627 C>T, p.R20Q, c.59 G>A

Heterozygous condition

rs10254120

Benign (0.164)

0.07568

  1. Genomic DNA sequencing of the patient’s lymphocyte tissue showed PMS2 mutation NM_00535.5:c.1577delA (p.Asp526fs) in exon 11. Her mother and younger brother also carried PMS2 mutations